Search Results - "AFFRONTI, M."

Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review by Molassiotis, A., Zhao, I.Y., Crichton, M., Olver, I., Fleury, M., Giusti, R., Scotte, F., Affronti, M.L.

“…Background Cancer treatment-related nausea and vomiting continue to be common and distressing symptoms for patients, despite improvements in antiemetics…”
Get full text

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis by Renna, S., Orlando, E., Macaluso, F. S., Maida, M., Affronti, M., Giunta, M., Sapienza, C., Rizzuto, G., Orlando, R., Dimarco, M., Cottone, M., Orlando, A.

Get full text

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting by Herrstedt, J., Clark-Snow, R., Ruhlmann, C.H., Molassiotis, A., Olver, I., Rapoport, B.L., Aapro, M., Dennis, K., Hesketh, P.J., Navari, R.M., Schwartzberg, L., Affronti, M.L., Garcia-Del-Barrio, M.A., Chan, A., Celio, L., Chow, R., Fleury, M., Gralla, R.J., Giusti, R., Jahn, F., Iihara, H., Maranzano, E., Radhakrishnan, V., Saito, M., Sayegh, P., Bosnjak, S., Zhang, L., Lee, J., Ostwal, V., Smit, T., Zilic, A., Jordan, K., Scotté, F.

“…•Nausea and vomiting are considered amongst the most troublesome adverse events for patients receiving antineoplastics.•The guideline covers emetic risk…”
Get full text

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience by Macaluso, F.S, Sapienza, C, Ventimiglia, M, Renna, S, Rizzuto, G, Orlando, R, Affronti, M, Orlando, E, Cottone, M, Orlando, A

Get full text

OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants by Macaluso, F.S, Maida, M, Renna, S, Orlando, E, Affronti, M, Sapienza, C, Dimarco, M, Orlando, R, Rizzuto, G, Cottone, M, Orlando, A

Get full text

P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience by Macaluso, F.S, Maida, M, Renna, S, Dimarco, M, Sapienza, C, Affronti, M, Orlando, E, Rizzuto, G, Orlando, R, Cottone, M, Orlando, A

Get full text

Low-grade fever: how to distinguish organic from non-organic forms by Affronti, M, Mansueto, P, Soresi, M, Abbene, A M, Affronti, A, Valenti, M, Giannitrapani, L, Montalto, G

“…Low-grade fever (LGF) is defined as a body temperature between 37.5 and 38.3 degrees C, which is below the classical value reported for fever of unknown origin…”
Get more information

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy by VREDENBURGH, J. J, MADAN, B, AFFRONTI, M. L, PETERS, W. P, CONIGLIO, D, ROSS, M, BROADWATER, G, NIEDZWIECKI, D, EDWARDS, J, MARKS, L, VANDEMARK, R, MCDONALD, C

“…The prognosis for patients with metastatic breast cancer remains poor. Metastatic breast cancer confined to the bones may have a better prognosis, especially…”
Get full text

Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support by RIZZIERI, D. A, VREDENBURGH, J. J, AFFRONTI, M. L, CONIGLIO, D, RUBIN, P, ELKORDY, M, LONG, G. D, CHAO, N. J, PETERS, W. P, JONES, R, ROSS, M, SHPALL, E. J, HUSSEIN, A, BROADWATER, G, BERRY, D, PETROS, W. P, GILBERT, C

“…We performed a retrospective review to determine predictive and prognostic factors in patients with metastatic breast cancer who received induction therapy,…”
Get full text

OC9 PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE by Affronti, A, Affronti, M, Soresi, M, Giannitrapani, L, La Spada, E, Campagna, E, Brunori, G, Montalto, G

Get full text

Impact of chemotherapy-induced nausea and vomiting (CINV) on emergency department (ED) visits and disruption of chemotherapy: results of a survey of oncology nurses by Rittenberg, C., Clark-Snow, R., Affronti, M.L.

Get full text

Neutrophil Migration Is Defective During Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Infusion After Autologous Bone Marrow Transplantation in Humans by Peters, William P., Stuart, Ann, Affronti, Mary Lou, Kim, Chul Soo, Coleman, R. Edward

“…We have previously reported that continuous intravenous (IV) administration of recombinant granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) to…”
Get full text

The Acute Phase Response in Sicilian Patients with Boutonneuse Fever Admitted to Hospitals in Palermo, 1992–1997 by Vitale, G., Mansueto, S., Gambino, G., Mocciaro, C., Spinelli, A., Rini, G.B., Affronti, M., Chifari, N., La Russa, C., Di Rosa, S., Colletti, P., Barbera, C., La Rosa, M., Di Bella, G., Ferlazzo, V., Milano, S., D'Agostino, P., Cillari, E.

“…Objectives: To study the modifications of some components of the acute phase response (APR) in Sicilian patients with boutonneuse fever (BF) caused by…”
Get full text

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial by Shpall, E J, Jones, R B, Bast, Jr, R C, Rosner, G L, Vandermark, R, Ross, M, Affronti, M L, Johnston, C, Eggleston, S, Tepperburg, M

“…We designed an ex vivo bone marrow treatment for breast cancer patients receiving high-dose chemotherapy and autologous bone marrow support (ABMS), using…”
Get more information

Safe and successful endoarterial infusion of liposomal amphotericin B in treatment of mucormycosis by Mansueto, P, Rizzo, M, Affronti, M, Malta, R, Carmina, E, Mansueto, S, Masellis, M, Rini, G B

“…Mucormycosis is a rare invasive mycotic infection treated by antifungini or amphotericin B. We describe the case of a patient with septic fever and a necrotic…”
Get more information

The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer by Jones, R B, Shpall, E J, Shogan, J, Affronti, M L, Coniglio, D, Hart, L, Halperin, E, Iglehart, J D, Moore, J, Gockerman, J

“…Forty-five patients have completed treatment with AFM, an intensive induction chemotherapy regimen composed of Adriamycin (doxorubicin, Adria Laboratories,…”
Get more information

P387 The addition of an immunosuppressant is an effective optimization strategy after loss of response to anti-TNF-alpha monotherapy in patients with inflammatory bowel disease: a two-year experience by Macaluso, F.S., Sapienza, C., Ventimiglia, M., Renna, S., Rizzuto, G., Orlando, R., Affronti, M., Orlando, E., Cottone, M., Orlando, A.

Get full text

Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas by Gururangan, S, Cokgor, L, Rich, J N, Edwards, S, Affronti, M L, Quinn, J A, Herndon, 2nd, J E, Provenzale, J M, McLendon, R E, Tourt-Uhlig, S, Sampson, J H, Stafford-Fox, V, Zaknoen, S, Early, M, Friedman, A H, Friedman, H S

“…Both Gliadel wafers [1,3-bis(2-chloroethyl)-1-nitrosourea] and temozolomide (TEMO) have been shown in independent studies to prolong survival of patients with…”
Get full text

Sexually transmitted diseases among foreigners in Italy by SULIGOI, B., GIULIANI, M.

“…A sentinel surveillance system for the control of sexually transmitted diseases (STD) among foreigners was developed in Italy in 1991. From January 1991 to…”
Get full text

Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever by MANSUETO, S, VITALE, G, MILANO, S, CILLARI, E, MOCCIARO, C, GAMBINO, G, COLLETTI, P, MANSUETO, P, SPINELLI, A, AFFRONTI, M, CHIFARI, N, ARCOLEO, F

“…The serum levels of β2‐microglobulin (β2‐M), soluble HLA class I antigen (sHLA‐I), soluble CD4 (sCD4) and CD8 (sCD8) were studied in 98 Sicilian patients with…”
Get full text